Rheumatoid Arthritis

Top Story

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate

Patients with low-disease RA on tofacitinib, methotrexate can safely withdraw methotrexate
September 12, 2019
In the Journals

Number of prior DMARDs, disease duration linked to diminished drug response in RA

September 9, 2019
Longer disease duration and a greater number of previous DMARDs in a patient’s history is associated with decreased response rates to adalimumab plus methotrexate…
In the JournalsPerspective

Telemedicine more commonly used by patients with higher RA activity

September 5, 2019
Video telemedicine, when it is offered, is more likely to be used by patients with rheumatoid arthritis who demonstrate higher disease activity, have more positive…
In the Journals

Golimumab efficacy in RA similar for patients older, younger than 65 years

September 4, 2019
IV golimumab, combined with methotrexate, is as efficacious among patients with rheumatoid arthritis who are aged 65 years and older as it is among those younger than 65…
More Headlines »
ABIM MOC CME

AWIR 2nd Annual Immunology Bootcamp Part 2: T- and B-Cell, IL-12, IL-17, and IL-23 Biology and Inhibitors

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »
Video
Meeting News

AVERT-2 fails to meet primary endpoint, but data advances the field for RA

November 6, 2018
More »
ABIM MOC CME

AWIR 2nd Annual Immunology Bootcamp Part 3: Signal Transduction and Biosimilars

This activity is supported by educational grants from AbbVie, Inc.; Amgen; Bristol-Myers Squibb; Pfizer, Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, psoriatic arthritis, vasculitis, and axial…
More »